Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New York attorney general reaches settlement with drug makers Ranbaxy and Teva
Yahoo/AP
Thursday, February 20, 2014 - 10:55am
tags:
New York, Ranbaxy, generics, Teva Pharmaceuticals
GW Pharmaceuticals: High As A Kite And Too Close To The Sun
Seeking Alpha
Thursday, February 20, 2014 - 10:54am
tags:
Medical Marijuana, GW Pharma
Oncology, Streamlined R&D Will Help Pfizer Going Forward
Forbes
Thursday, February 20, 2014 - 9:31am
tags:
R&D, Pfizer, oncology
3 Biotech Stocks to Bet on this Earnings Season
Yahoo/Zacks.com
Thursday, February 20, 2014 - 8:50am
tags:
earnings, Medivation, United Therapeutics, Idenix
GlaxoSmithKline's COPD drug Anoro receives European green light
Reuters
Thursday, February 20, 2014 - 8:44am
tags:
GSK, COPD, Europe, Anoro, Theravance
Medtronic lands U.S., E.U. wins for miniature cardiac monitor
Mass Device
Thursday, February 20, 2014 - 8:28am
tags:
Europe, cardiac monitors, Medtronic, FDA, devices, Reveal LINQ
Brent Saunders: Chuck Norris Of Big Pharma M&A
Forbes
Thursday, February 20, 2014 - 8:24am
tags:
Forest Labs, M&A, Brent Saunders, Actavis
Can AstraZeneca plc Make £5 Billion Profit?
Motley Fool
Thursday, February 20, 2014 - 8:21am
tags:
AstraZeneca
5 Questions for MannKind
Motley Fool
Thursday, February 20, 2014 - 8:21am
tags:
MannKind, Afrezza, diabetes
Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
Yahoo/Benzinga
Thursday, February 20, 2014 - 8:19am
tags:
Raptor Pharmaceuticals, RP103, Huntington's disease
Pluristem Therapeutics submits FDA orphan drug application for PLX-PAD
The Fly on the Wall
Thursday, February 20, 2014 - 8:14am
tags:
FDA, orphan drugs, Pluristem Therapeutics, PLX-PAD, preeclampsia
Galena Biopharma: The Oncologist's Perspective On A Life Saving Therapy
Seeking Alpha
Thursday, February 20, 2014 - 8:12am
tags:
Galena Biopharma, NeuVax, Dendreon, Provenge, prostate cancer, vaccines, breast cancer
Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict
Bloomberg
Thursday, February 20, 2014 - 8:09am
tags:
Roche, Avastin, glioblastoma
Bayer, Novartis, others eye Merck's consumer health unit - sources
Yahoo/Reuters
Thursday, February 20, 2014 - 8:08am
tags:
Merck, consumer health, M&A, Bayer, Novartis, Reckitt Benckiser, Procter & Gamble
Novo Nordisk targets Mexico for early obesity drug launch
Fierce Pharma
Wednesday, February 19, 2014 - 12:57pm
tags:
Novo Nordisk, obesity, Mexico, liraglutide
3 Small Cap Biotechs Developing Novel Cancer Treatments
Motley Fool
Wednesday, February 19, 2014 - 12:56pm
tags:
Inovio, VGX-3100, Cervical Intraepithelial Neoplasia, MM-398, Merrimack Pharmaceuticals, acute myeloid leukemia, vosaroxin, Sunesis
Arrowhead: A Functional Cure For The Hepatitis B Virus
Seeking Alpha
Wednesday, February 19, 2014 - 12:49pm
tags:
Arrowhead Research, hepatitis B, RNAi
Furiex Said to Seek Buyer as Experimental Drug Meets Targets
Bloomberg
Wednesday, February 19, 2014 - 12:48pm
tags:
Furiex Pharmaceuticals, eluxadoline, M&A, irritable bowel syndrome
Athersys: Two Crucial Near-Term Events
Seeking Alpha
Wednesday, February 19, 2014 - 12:47pm
tags:
Athersys, MultiStem, stem cells, Osiris, RTI Surgical
Actavis-Forest Bid Shines Light on Valeant Next: Real M&A
Bloomberg
Wednesday, February 19, 2014 - 11:18am
tags:
Actavis, Forest Labs, M&A, Valeant Pharmaceuticals, Mylan, Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.